| Secondary |
| Hypertension |
12.7% |
| Product Used For Unknown Indication |
10.7% |
| Cardiac Failure |
10.3% |
| Chronic Obstructive Pulmonary Disease |
10.3% |
| Atrial Fibrillation |
6.0% |
| Sepsis |
5.6% |
| Depression |
4.8% |
| Oedema |
4.8% |
| Thrombosis Prophylaxis |
4.4% |
| Osteoporosis |
4.0% |
| Sedation |
3.6% |
| Cardiac Disorder |
3.2% |
| Hyperuricaemia |
2.8% |
| Prophylaxis |
2.8% |
| Tachyarrhythmia |
2.8% |
| Alcohol Withdrawal Syndrome |
2.4% |
| Coronary Artery Disease |
2.4% |
| Drug Use For Unknown Indication |
2.4% |
| Thyroid Disorder |
2.4% |
| Diabetes Mellitus |
2.0% |
|
| Stevens-johnson Syndrome |
20.8% |
| Toxic Epidermal Necrolysis |
20.8% |
| Thyroid Disorder |
16.7% |
| Aphasia |
8.3% |
| Ventricular Hypertrophy |
8.3% |
| Weight Decreased |
8.3% |
| Inappropriate Schedule Of Drug Administration |
4.2% |
| Renal Failure |
4.2% |
| Suicide Attempt |
4.2% |
| Therapeutic Agent Toxicity |
4.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
33.3% |
| Drug Use For Unknown Indication |
11.8% |
| Hypertension |
11.6% |
| Atrial Fibrillation |
10.9% |
| Rheumatoid Arthritis |
4.4% |
| Cardiac Failure |
3.3% |
| Diabetes Mellitus |
3.3% |
| Coronary Artery Disease |
2.8% |
| Pain |
2.5% |
| Prophylaxis |
2.2% |
| Cerebrovascular Accident Prophylaxis |
2.1% |
| Colorectal Cancer Metastatic |
1.5% |
| Hyperparathyroidism Secondary |
1.5% |
| Chronic Obstructive Pulmonary Disease |
1.4% |
| Renal Failure Chronic |
1.4% |
| Hypothyroidism |
1.3% |
| Immunosuppression |
1.3% |
| Type 2 Diabetes Mellitus |
1.3% |
| Metastatic Renal Cell Carcinoma |
1.2% |
| Arrhythmia |
1.1% |
|
| Cardiac Failure |
8.6% |
| Thrombocytopenia |
7.5% |
| Renal Failure |
6.5% |
| Death |
5.4% |
| Hepatitis Cholestatic |
5.4% |
| Pneumonia |
5.4% |
| Respiratory Failure |
5.4% |
| Tachycardia |
5.4% |
| Weight Decreased |
5.4% |
| Anaemia |
4.3% |
| Hypotension |
4.3% |
| Nausea |
4.3% |
| Periodontal Disease |
4.3% |
| Renal Failure Acute |
4.3% |
| Sepsis |
4.3% |
| Urinary Tract Infection |
4.3% |
| Venous Thrombosis Limb |
4.3% |
| Ventricular Fibrillation |
4.3% |
| Cerebrovascular Accident |
3.2% |
| Dyspnoea |
3.2% |
|
| Interacting |
| Drug Use For Unknown Indication |
100.0% |
|
|
